SEC 13F Intelligence

Point72 Europe (London) LLP / PRCT

Point72 Europe (London) LLP’s Procept Biorobotics Corp Position

Does Point72 Europe (London) LLP own Procept Biorobotics Corp (PRCT)? Not currently — the last reported position was 259.2K shares worth $16M in Q2 2024; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$16M
Q2 2024
Shares
259.2K
% of Portfolio
+1.30%
Quarters Held
4
position exited

Position History PRCT

Reported value by quarter
Q3 ’23: $13MQ3 ’23Q4 ’23: $22MQ4 ’23Q1 ’24: $16MQ1 ’24Q2 ’24: $16MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024259.2K$16M+1.30%
Q1 2024320.4K$16M+1.41%
Q4 2023530.1K$22M+2.78%
Q3 2023406.3K$13M+0.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Europe (London) LLP’s full portfolio or all institutional holders of PRCT.